Cite
Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data.
MLA
Roussin, Anne, et al. “Increase of High‐risk Tramadol Use and Harmful Consequences in France from 2013 to 2018: Evidence from the Triangulation of Addictovigilance Data.” British Journal of Clinical Pharmacology, vol. 88, no. 8, Aug. 2022, pp. 3789–802. EBSCOhost, https://doi.org/10.1111/bcp.15323.
APA
Roussin, A., Soeiro, T., Fouque, C., Jouanjus, E., Frauger, E., Fouilhé, N., Mallaret, M., Micallef, J., Lapeyre, M. M., Batisse, A., Chevallier, C., Daveluy, A., Deheul, S., Fournier, C. C., Guerlais, M., Le Boisselier, R., Pérault, P. M., Roy, S., & Tournebize, J. (2022). Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data. British Journal of Clinical Pharmacology, 88(8), 3789–3802. https://doi.org/10.1111/bcp.15323
Chicago
Roussin, Anne, Thomas Soeiro, Charlotte Fouque, Emilie Jouanjus, Elisabeth Frauger, Nathalie Fouilhé, Michel Mallaret, et al. 2022. “Increase of High‐risk Tramadol Use and Harmful Consequences in France from 2013 to 2018: Evidence from the Triangulation of Addictovigilance Data.” British Journal of Clinical Pharmacology 88 (8): 3789–3802. doi:10.1111/bcp.15323.